v3.25.2
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Sales, net
Cost of Sales 47,130
Gross Loss (47,130)
Operating Expenses    
General and administrative expenses 202,890 1,646,902
Salaries and wages 33,277 382,383
Research and development and other service providers 27,626 793,175
Total Operating Expenses 263,793 2,822,460
Operating Loss (310,923) (2,822,460)
Other Income (Expense)    
Liquidated damages (710,375)
Change in fair value of derivative liability 48,816 115,296
Loss on settlement of debts (33,510) (3,824,936)
Write-off of accounts receivable (50,000)
Interest expense (116,822) (413,270)
Total Other Expense (861,891) (4,122,910)
Loss Before Taxes (1,172,814) (6,945,370)
Income Taxes
Net Loss $ (1,172,814) $ (6,945,370)
Basic loss per common share (in Dollars per share) $ 0 $ (0.37)
Diluted loss per common share (in Dollars per share) $ 0 $ (0.37)
Weighted average number of common shares outstanding - basic (in Shares) 3,262,761,260 18,539,389
Weighted average number of common shares outstanding - diluted (in Shares) 3,262,761,260 18,539,389